RESEARCH ON THE SECRETORY ACTIVITY OF KEY CYTOKINES IN NATURAL KILLER CELLS FROM PROSTATE CANCER PATIENTS

Ngọc Tuấn Nguyễn, Hoàng Phương Nguyễn, Trọng Phúc Nguyễn, Thế Hải Phùng, Trung Kiên Hoàng, Đặng Dũng Nguyễn, Khắc Đại Đỗ

Main Article Content

Abstract

Objectives: The study aimed to investigate the key cytokines secretion characteristics of natural killer (NK) cells from prostate cancer (PCa) patients using in vitro culture and to assess these characteristics when NK cells are co-cultured with PCa cell lines. Methods: NK cells were isolated from the peripheral blood of PCa patients. These cells were cultured and expanded, and the culture supernatant was collected to evaluate cytokine secretion capabilities. Expanded NK cells were then co-cultured with the PCa cell line (PC3), and the supernatant was harvested at various time points to assess cytokine secretion activity. Results: The concentrations of the cytokines IFN-γ, TNF-α, and GM-CSF exhibited average fold increases of 1.9, 2.7, and 4.5, respectively. The cytokine concentrations in the co-culture supernatant showed significant changes at 24 hours compared to 6 hours and 0 hours. Conclusion: NK cell cytokine levels significantly increased during the expansion process and when NK cells were co-cultured with a prostate cancer cell line

Article Details

References

Mira M Shenouda, Amy Gillgrass, Tina Nham., et al. 2017; Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. Breast Cancer Res., 19(1):76.
2. Trần Mai Linh, Nguyễn Quý Linh, Trần Vân Khánh và cs. 2020; Nuôi cấy hoạt hóa, tăng sinh tế bào nk trên bệnh nhân ung thư phổi không tế bào nhỏ. Tạp chí nghiên cứu Y học., (138):2.
3. Minh-Trang Thi Phan, Seung-Hwan Lee, Sang-Ki Kim., et al. 2016; Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells. Methods Mol Biol., 1441:167-74.
4. Janine E. Melsen, Maria Themeli, Monique M. van Ostaijen-Ten Dam., et al. 2020; Protocol for Isolation, Stimulation and Functional Profiling of Primary and iPSC-derived Human NK Cells. Bio Protoc., 10(23): e3845.
5. Alici, E., Sutlu, T., Björkstrand, B., Gilljam, M., et al. 2008; Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components. Blood, The Journal of the American Society of Hematology, 111(6), 3155-3162.
6. Du, N., Guo, F., Wang, Y., & Cui, J. 2021; NK cell therapy: a rising star in cancer treatment. Cancers, 13(16), 4129.
7. Lapteva, N., Szmania, S. M., van Rhee, F., & Rooney, C. M. 2014; Clinical grade purification and expansion of natural killer cells. Critical Reviews™ in Oncogenesis, 19(1-2).